Biological Therapy Analysis & Statistics, March 2015 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

31-60 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Amarna Therapeutics B.V. - Product Pipeline Review - 2015

Amarna Therapeutics B.V. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Amarna Therapeutics B.V. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Amarna Therapeutics B.V. - Product Pipeline Review - 2015’, provides an overview of the Amarna Therapeutics ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical, Biopharmaceutical, Research and Development
  • Countries : World, Netherlands
Plerixafor  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Plerixafor - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Biological Therapy
The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

  • $ 1 395
  • Industry report
  • June 2015
  • by BioInformant Worldwide, L.L.C.

Purpose of Report: The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2015

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Hematopoietic Stem Cell Transplantation- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hematopoietic Stem Cell Transplantation. The ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2015

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Broad Spectrum Chemokine Inhibitors (BSCIs)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Broad Spectrum Chemokine Inhibitors (BSCIs). ...

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2015

Anti GM-CSF Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti GM-CSF Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti GM-CSF Antibody. The main objective of this report to track ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2015

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Activation Protein (FAP or Seprase) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Activation Protein ...

  • Industries : Biological Therapy, Sport Nutritional, Biopharmaceutical, Biotechnology
G-CSF Inhibitors -Pipeline Insights, 2015

G-CSF Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, G-CSF Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the G-CSF Inhibitors. The main objective of this report to track competito ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2015

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, B-Cell Activating Factor (BAFF) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the B-Cell Activating Factor (BAFF) Inhibitors. ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor (FGF) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor (FGF) Inhibitors. ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2015

Integrase Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Integrase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Integrase Inhibitors. The main objective of this report to track ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor (FGFR) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2015

GM-CSF Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, GM-CSF Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the GM-CSF Inhibitors. The main objective of this report to track competito ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor 1 (FGF-1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor 1 (FGF-1) Inhibitors. ...

  • Industries : Biological Therapy
Notch Signaling Pathway Inhibitors -Pipeline Insights, 2015

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Notch Signaling Pathway Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Notch Signaling Pathway Inhibitors. The main objective ...

  • Industries : Biological Therapy
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2015

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Matrix ...

  • Industries : Biological Therapy
Interleukin (IL) Inhibitors -Pipeline Insights, 2015

Interleukin (IL) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Interleukin (IL) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin (IL) Inhibitors. The main objective of this ...

  • Industries : Diagnostics, Diagnostics, Biological Therapy, In Vitro Diagnostic, In Vitro Diagnostic
Growth Hormone Antagonists -Pipeline Insights, 2015

Growth Hormone Antagonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Growth Hormone Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Growth Hormone Antagonists. The main objective of this report ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Growth Hormone (GH) Agonists -Pipeline Insights, 2015

Growth Hormone (GH) Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Growth Hormone (GH) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Growth Hormone (GH) Agonists. The main objective of this ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2015

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Chemokine ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2015

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Hepatocyte growth factor (HGF) mimetic- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hepatocyte growth factor (HGF) mimetic. The main ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor (FGFR) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2015

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Fibroblast Growth Factor Recepto ...

  • Industries : Biological Therapy
Chemokine Receptor Antagonists -Pipeline Insights, 2015

Chemokine Receptor Antagonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Chemokine Receptor Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Chemokine Receptor Antagonists. The main objective of ...

  • Industries : Biological Therapy
T Cell Inhibitors -Pipeline Insights, 2015

T Cell Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, T Cell Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T Cell Inhibitors. The main objective of this report to track competito ...

  • Industries : Biological Therapy
 Growth Hormone Deficiency-Pipeline Insights, 2015

Growth Hormone Deficiency-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Growth Hormone Deficiency- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Growth Hormone Deficiency. The main objective of this report ...

  • Industries : Biological Therapy, Biopharmaceutical
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2015

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Interferon-Alpha/Beta Receptor Binders- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interferon-Alpha/Beta Receptor Binders. The main ...

  • Industries : Office Supply and Stationery, Office Goods, Biological Therapy

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.